Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis

J Neurosci Res. 2018 Jun;96(6):1021-1042. doi: 10.1002/jnr.24224. Epub 2018 Feb 15.

Abstract

Multiple sclerosis (MS) is a chronic, progressive disorder of the central nervous system (CNS) that affects more than two million people worldwide. Several animal models resemble MS pathology; the most employed are experimental autoimmune encephalomyelitis (EAE) and toxin- and/or virus-induced demyelination. In this review we will summarize our knowledge on the utility of different animal models in MS research. Although animal models cannot replicate the complexity and heterogeneity of the MS pathology, they have proved to be useful for the development of several drugs approved for treatment of MS patients. This review focuses on EAE because it represents both clinical and pathological features of MS. During the past decades, EAE has been effective in illuminating various pathological processes that occur during MS, including inflammation, CNS penetration, demyelination, axonopathy, and neuron loss mediated by immune cells.

Keywords: EAE; ethidium bromide; glial cells; lysolecithin toxin and virus-induced demyelination; multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Encephalomyelitis, Autoimmune, Experimental / etiology*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Humans
  • Multiple Sclerosis / etiology*
  • Multiple Sclerosis / pathology